These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 8610978)

  • 1. Antigen-specific TGF-beta1 secretion with bovine myelin oral tolerization in multiple sclerosis.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    Ann N Y Acad Sci; 1996 Feb; 778():251-7. PubMed ID: 8610978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients.
    Fukaura H; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Hafler DA
    J Clin Invest; 1996 Jul; 98(1):70-7. PubMed ID: 8690806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.
    Hafler DA; Kent SC; Pietrusewicz MJ; Khoury SJ; Weiner HL; Fukaura H
    Ann N Y Acad Sci; 1997 Dec; 835():120-31. PubMed ID: 9616767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine secretion of myelin basic protein reactive T cells in patients with multiple sclerosis.
    Windhagen A; Anderson DE; Carrizosa A; Balashov K; Weiner HL; Hafler DA
    J Neuroimmunol; 1998 Nov; 91(1-2):1-9. PubMed ID: 9846813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity pattern and cytokine profile of T cells primed by myelin peptides in multiple sclerosis and healthy individuals.
    Tejada-Simon MV; Hong J; Rivera VM; Zhang JZ
    Eur J Immunol; 2001 Mar; 31(3):907-17. PubMed ID: 11241296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein and proteolipid protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis.
    Zhang J; Markovic-Plese S; Lacet B; Raus J; Weiner HL; Hafler DA
    J Exp Med; 1994 Mar; 179(3):973-84. PubMed ID: 7509366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.
    Weiner HL; Mackin GA; Matsui M; Orav EJ; Khoury SJ; Dawson DM; Hafler DA
    Science; 1993 Feb; 259(5099):1321-4. PubMed ID: 7680493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis.
    Schmidt S; Linington C; Zipp F; Sotgiu S; de Waal Malefyt R; Wekerle H; Hohlfeld R
    Brain; 1997 Aug; 120 ( Pt 8)():1437-45. PubMed ID: 9278633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myelin-specific tolerance attenuates the progression of a virus-induced demyelinating disease: implications for the treatment of MS.
    Neville KL; Padilla J; Miller SD
    J Neuroimmunol; 2002 Feb; 123(1-2):18-29. PubMed ID: 11880145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine secretion profile of myelin basic protein-specific T cells in multiple sclerosis.
    Rohowsky-Kochan C; Molinaro D; Cook SD
    Mult Scler; 2000 Apr; 6(2):69-77. PubMed ID: 10773850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term human coronavirus-myelin cross-reactive T-cell clones derived from multiple sclerosis patients.
    Boucher A; Desforges M; Duquette P; Talbot PJ
    Clin Immunol; 2007 Jun; 123(3):258-67. PubMed ID: 17448727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal single-cell cytokine responses reveal recurrent autoimmune myelin reactivity in relapsing--remitting multiple sclerosis patients.
    Moldovan IR; Rudick RA; Cotleur AC; Born SE; Lee JC; Karafa MT; Pelfrey CM
    Mult Scler; 2005 Jun; 11(3):251-60. PubMed ID: 15957503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell reactivity to multiple myelin antigens in multiple sclerosis patients and healthy controls.
    Hellings N; Barée M; Verhoeven C; D'hooghe MB; Medaer R; Bernard CC; Raus J; Stinissen P
    J Neurosci Res; 2001 Feb; 63(3):290-302. PubMed ID: 11170179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulse cyclophosphamide plus methylprednisolone induces myelin-antigen-specific IL-4-secreting T cells in multiple sclerosis patients.
    Takashima H; Smith DR; Fukaura H; Khoury SJ; Hafler DA; Weiner HL
    Clin Immunol Immunopathol; 1998 Jul; 88(1):28-34. PubMed ID: 9683547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99).
    Hemmer B; Vergelli M; Calabresi P; Huang T; McFarland HF; Martin R
    J Neurosci Res; 1996 Sep; 45(6):852-62. PubMed ID: 8892097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
    Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
    Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased CNS inflammation and absence of clinical exacerbation of disease after six months oral administration of bovine myelin in diseased SJL/J mice with chronic relapsing experimental autoimmune encephalomyelitis.
    al-Sabbagh AM; Goad EP; Weiner HL; Nelson PA
    J Neurosci Res; 1996 Aug; 45(4):424-9. PubMed ID: 8872902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant T cell responses to myelin antigens during clinical exacerbation in patients with multiple sclerosis.
    Tejada-Simon MV; Zang YC; Yang D; Hong J; Li S; Singh RA; Van den Berg-Loonen E; Killian JM; Rivera VM; Zhang JZ
    Int Immunol; 2000 Dec; 12(12):1641-50. PubMed ID: 11099303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor T cells generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor beta after antigen-specific triggering.
    Miller A; Lider O; Roberts AB; Sporn MB; Weiner HL
    Proc Natl Acad Sci U S A; 1992 Jan; 89(1):421-5. PubMed ID: 1370356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.